amotosalen has been researched along with Angiitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benamara, A; Coppo, P; Garraud, O; Guignier, C; Mariat, C; Oriol, P | 1 |
| Ciaravino, V; Cimino, G; McCullough, T; Sullivan, T | 1 |
2 other study(ies) available for amotosalen and Angiitis
| Article | Year |
|---|---|
Amotosalen-inactivated plasma is as equally well tolerated as quarantine plasma in patients undergoing large volume therapeutic plasma exchange.
Topics: Blood Preservation; Blood Volume; Blood-Borne Pathogens; Furocoumarins; Glomerulosclerosis, Focal Segmental; Graft Rejection; Humans; Kidney Transplantation; Photosensitizing Agents; Plasma; Plasma Exchange; Retrospective Studies; Thrombotic Microangiopathies; Time Factors; Ultraviolet Rays; Vasculitis; Virus Inactivation | 2018 |
Preclinical safety profile of plasma prepared using the INTERCEPT Blood System.
Topics: Animals; Blood Specimen Collection; Blood Transfusion; Dermatitis, Phototoxic; Donor Selection; Female; Furocoumarins; Humans; In Vitro Techniques; Mice; Mutation; Neoplasms, Experimental; Photochemistry; Photosensitizing Agents; Plasma; Plasmapheresis; Pregnancy; Reproduction; Safety; Transfusion Reaction; Vasculitis | 2003 |